Sei Investments Co. cut its stake in shares of Haleon plc (NYSE:HLN – Free Report) by 1.6% during the 4th quarter, Holdings ...

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other stocks Jim Cramer discussed. In a recent appearance on CNBC's Squawk on the Street, Jim Cramer ...

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

Haleon PLC closed 6.66% short of its 52-week high of £4.18, which the company reached on March 4th.

Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...

Haleon (NYSE:HLN – Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a return on ...

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against other stocks that lead Monday’s charge amid market bloodbath. The stock market kicked off the trading ...

Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.

Haleon PLC closed 6.80% below its 52-week high of £4.18, which the company reached on March 4th.

In a report released on March 20, Karel Zoete from Kepler Capital maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price ...